In This Section

Advocacy Detail

ASPET Comment Letter to DEA on Schedules of Controlled Substances: Placement of 2,5- dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4- chloroamphetamine (DOC) in Schedule I

January 12, 2024

This letter provides comments to the DEA on Schedules of Controlled Substances: Placement of 2,5- dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4- chloroamphetamine (DOC) in Schedule I 

ASPET Comments DOI and DOC Placement
Categories:
  • Statement
  • Latest ASPET News
  • Advocacy News

Job Postings